These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7941964)

  • 1. S-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of clinical studies.
    Bressa GM
    Acta Neurol Scand Suppl; 1994; 154():7-14. PubMed ID: 7941964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind, randomized parallel-group, efficacy and safety study of intramuscular S-adenosyl-L-methionine 1,4-butanedisulphonate (SAMe) versus imipramine in patients with major depressive disorder.
    Pancheri P; Scapicchio P; Chiaie RD
    Int J Neuropsychopharmacol; 2002 Dec; 5(4):287-94. PubMed ID: 12466028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, placebo-controlled study of S-adenosyl-L-methionine in depressed postmenopausal women.
    Salmaggi P; Bressa GM; Nicchia G; Coniglio M; La Greca P; Le Grazie C
    Psychother Psychosom; 1993; 59(1):34-40. PubMed ID: 8441793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of oral and intramuscular S-adenosyl-L-methionine 1,4-butanedisulfonate (SAMe) in the treatment of major depression: comparison with imipramine in 2 multicenter studies.
    Delle Chiaie R; Pancheri P; Scapicchio P
    Am J Clin Nutr; 2002 Nov; 76(5):1172S-6S. PubMed ID: 12418499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral S-adenosylmethionine in depression: a randomized, double-blind, placebo-controlled trial.
    Kagan BL; Sultzer DL; Rosenlicht N; Gerner RH
    Am J Psychiatry; 1990 May; 147(5):591-5. PubMed ID: 2183633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between the antidepressant activity and of S-adenosylmethionine (SAMe) and that of some tricyclic drugs.
    Miccoli L; Porro V; Bertolino A
    Acta Neurol (Napoli); 1978; 33(3):243-55. PubMed ID: 371351
    [No Abstract]   [Full Text] [Related]  

  • 7. Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants.
    Freeman MP; Mischoulon D; Tedeschini E; Goodness T; Cohen LS; Fava M; Papakostas GI
    J Clin Psychiatry; 2010 Jun; 71(6):682-8. PubMed ID: 20573327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapidity of onset of the antidepressant effect of parenteral S-adenosyl-L-methionine.
    Fava M; Giannelli A; Rapisarda V; Patralia A; Guaraldi GP
    Psychiatry Res; 1995 Apr; 56(3):295-7. PubMed ID: 7568552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
    Tollefson GD; Holman SL; Sayler ME; Potvin JH
    J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature.
    Altshuler LL; Bauer M; Frye MA; Gitlin MJ; Mintz J; Szuba MP; Leight KL; Whybrow PC
    Am J Psychiatry; 2001 Oct; 158(10):1617-22. PubMed ID: 11578993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of S-adenosyl-L-methionine in speeding the onset of action of imipramine.
    Berlanga C; Ortega-Soto HA; Ontiveros M; Senties H
    Psychiatry Res; 1992 Dec; 44(3):257-62. PubMed ID: 1289923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for S-adenosyl-L-methionine (SAM-e) for the treatment of major depressive disorder.
    Papakostas GI
    J Clin Psychiatry; 2009; 70 Suppl 5():18-22. PubMed ID: 19909689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early clinical double-blind study with S-adenosyl-L-methionine: a new potential antidepressant.
    Küfferle B; Grünberger J
    Adv Biochem Psychopharmacol; 1982; 32():175-80. PubMed ID: 7046363
    [No Abstract]   [Full Text] [Related]  

  • 14. The antidepressant potential of oral S-adenosyl-l-methionine.
    Rosenbaum JF; Fava M; Falk WE; Pollack MH; Cohen LS; Cohen BM; Zubenko GS
    Acta Psychiatr Scand; 1990 May; 81(5):432-6. PubMed ID: 2113347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affective illness and S-adenosyl methionine: a preliminary report.
    Carney MW; Edeh J; Bottiglieri T; Reynolds EM; Toone BK
    Clin Neuropharmacol; 1986; 9(4):379-85. PubMed ID: 2425961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence.
    Mischoulon D; Fava M
    Am J Clin Nutr; 2002 Nov; 76(5):1158S-61S. PubMed ID: 12420702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SAMe versus placebo: a double blind comparison in major depressive disorders.
    Muscettola G; Galzenati M; Balbi A
    Adv Biochem Psychopharmacol; 1982; 32():151-6. PubMed ID: 7046362
    [No Abstract]   [Full Text] [Related]  

  • 18. S-adenosylmethionine treatment of depression: a controlled clinical trial.
    Bell KM; Plon L; Bunney WE; Potkin SG
    Am J Psychiatry; 1988 Sep; 145(9):1110-4. PubMed ID: 3046382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term efficacy of tricyclic antidepressants revisited: a meta-analytic study.
    Storosum JG; Elferink AJ; van Zwieten BJ; van den Brink W; Gersons BP; van Strik R; Broekmans AW
    Eur Neuropsychopharmacol; 2001 Apr; 11(2):173-80. PubMed ID: 11313164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J; Barkin RL
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.